Healthcare Services

Pemphigus Vulgaris Market Forecast 2026–2035 Highlighting Market Data Patterns and Industry Insights

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Pemphigus Vulgaris Market In 2026 And What Value Is Projected For 2030?

The pemphigus vulgaris market has demonstrated robust expansion in recent years. Its valuation is anticipated to climb from $1.94 billion in 2025 to $2.09 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.7%. The market’s historical development can be ascribed to factors including limited awareness and delayed diagnosis, a reliance on corticosteroids, insufficient access to dermatology specialists, the high cost of immunosuppressive therapies, and fragmented clinical data and registries.

The pemphigus vulgaris market is projected to experience substantial expansion over the coming years. This market is anticipated to reach $2.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.5%. The anticipated growth during the forecast period is fueled by several factors, including the increasing integration of targeted immunotherapies, a greater reliance on biologics and monoclonal antibodies, the expansion of teledermatology and remote patient monitoring solutions, ongoing improvements in early detection diagnostic tools, and heightened patient awareness alongside robust support initiatives. Key trends shaping the forecast period encompass the escalating utilization of AI for early diagnosis and predicting prognosis, the expanding embrace of genomics-based personalized therapies, the incorporation of cloud computing and big data for comprehensive patient data management, the deployment of IoT-enabled devices for continuous remote patient monitoring, and the application of smart manufacturing techniques in the production of immunosuppressive drugs.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22094&type=smp

What Key Drivers Are Influencing The Growth Of The Pemphigus Vulgaris Market?

The increasing occurrence of autoimmune diseases is projected to drive the expansion of the pemphigus vulgaris market moving forward. Autoimmune diseases are a category of conditions where the immune system mistakenly targets and damages the body’s healthy cells, tissues, or organs. The incidence of autoimmune diseases is on the rise due to genetic predispositions, environmental triggers, and changes in lifestyle. Genetic factors play a significant part, as individuals with a family history of these diseases are more prone to developing them due to inherited vulnerabilities in their immune systems. As autoimmune diseases become more widespread because of genetic susceptibility, environmental factors, and lifestyle shifts, more individuals are receiving diagnoses for conditions like pemphigus vulgaris, thereby fueling the demand for sophisticated therapies. For instance, in January 2025, according to the Mayo Clinic Health System, a US-based network offering comprehensive healthcare, the global incidence and prevalence of autoimmune diseases are increasing, with estimated annual rises of 19.1% and 12.5%, respectively. Therefore, the prevalence of autoimmune diseases is a primary driver for the growth of the pemphigus vulgaris market.

What Are The Key Segments Of The Pemphigus Vulgaris Market?

The pemphigus vulgaris market covered in this report is segmented –

1) By Diagnosis And Treatment: Diagnosis, Treatment

2) By Population Type: Pediatric, Adults, Geriatric

3) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

4) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Diagnosis: Clinical Examination, Skin Biopsy, Direct Immunofluorescence, Serological Tests, Polymerase Chain Reaction (PCR)

2) By Treatment: Pharmacological Therapy, Non-Pharmacological Therapy

Which Trends Are Influencing The Pemphigus Vulgaris Market?

Key companies operating in the pemphigus vulgaris market are channeling their efforts into investment solutions to bolster treatment effectiveness and broaden the array of therapeutic choices. These investment solutions encompass financial strategies and resources allocated towards the development of treatments, research initiatives, and their subsequent market introduction. For example, in January 2023, the Patient Access Network Foundation (PAN) Foundation, a non-profit organization situated in the US, introduced a financial assistance program designed to provide up to $6,600 annually for eligible pemphigus vulgaris patients to help cover costs such as deductibles, copays, and coinsurance. To qualify for this financial aid, patients must be undergoing treatment for pemphigus vulgaris, possess Medicare health insurance that covers their essential medications, and have an income level at or below 400% of the federal poverty level. Beyond financial aid, the PAN Foundation additionally provides transportation assistance and links patients with appropriate support organizations.

Who Are The Leading Companies Operating In The Pemphigus Vulgaris Market?

Major companies operating in the pemphigus vulgaris market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Amgen Inc., Sanofi S.A, Biogen Inc., Genentech, Genmab A/S, argenx SE, Daewoong Pharmaceutical Co. Ltd., HanAll Biopharma Co. Ltd., Artiva Biotherapeutics, Cabaletta Bio Inc., SinoMab BioScience Limited, Topas Therapeutics GmbH, Principia Biopharma Inc., Serpin Pharma LLC, Syntimmune Inc., International Pemphigus & Pemphigoid Foundation

Read the full pemphigus vulgaris market report here:

https://www.thebusinessresearchcompany.com/report/pemphigus-vulgaris-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Pemphigus Vulgaris Market?

North America was the largest region in the pemphigus vulgaris market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pemphigus vulgaris market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pemphigus Vulgaris Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22094&type=smp

Browse Through More Reports Similar to the Global Pemphigus Vulgaris Market 2026, By The Business Research Company

Rare Inflammatory Disease Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Uterine Fibroids Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/uterine-fibroids-treatment-global-market-report

Chlamydia Infection Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/chlamydia-infection-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795